|
1
|
Marcus CS, Maxwell GL, Darcy KM, Hamilton
CA and McGuire WP: Current approaches and challenges in managing
and monitoring treatment response in ovarian cancer. J Cancer.
5:25–30. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oronsky B, Ray CM, Spira AI, Trepel JB,
Carter CA and Cottrill HM: A brief review of the management of
platinum- resistant-platinum-refractory ovarian cancer. Med Oncol.
34:1032017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walker JL, Powell CB, Chen Lm, Carter J,
Bae Jump VL, Parker LP, Borowsky ME and Gibb RK: Society of
gynecologic oncology recommendations for the prevention of ovarian
cancer. Cancer. 121:2108–2120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matz M, Coleman MP, Carreira H, Salmerón
D, Chirlaque MD and Allemani C; CONCORD Working Group, : Worldwide
comparison of ovarian cancer survival: Histological group and stage
at diagnosis (CONCORD-2). Gynecol Oncol. 144:396–404. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiménez-Sánchez A, Memon D, Pourpe S,
Veeraraghavan H, Li Y, Vargas HA, Gill MB, Park KJ, Zivanovic O,
Konner J, et al: Heterogeneous tumor-immune microenvironments among
differentially growing metastases in an ovarian cancer patient.
Cell. 170:927–938. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hillman RT, Lu KH and Futreal PA: A novel
genomic rearrangement signature to predict poor survival among
women with high grade serous ovarian cancer. J Clin Oncol. 35
(Suppl 15):S55092017. View Article : Google Scholar
|
|
7
|
Lengyel E: Ovarian cancer development and
metastasis. Am J Pathol. 177:1053–1064. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bast RC, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Naora H and Montell DJ: Ovarian cancer
metastasis: Integrating insights from disparate model organisms.
Nat Rev Cancer. 5:355–366. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo Z, Wang Q, Lau WB, Lau B, Xu L, Zhao
L, Yang H, Feng M, Xuan Y, Yang Y, et al: Tumor microenvironment:
The culprit for ovarian cancer metastasis? Cancer Lett.
377:174–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He G, Liu X, Qin W, Chen Q, Wang X, Yang
Y, Zhou J, Xu Y, Gu N, Feng G, et al: MPZL1/PZR, a novel candidate
predisposing schizophrenia in Han Chinese. Mol Psychiatry.
11:748–751. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beigbeder A, Chartier FJ and Bisson N:
MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11
phosphatase in HER2-positive breast cancer cells. Sci Rep.
7:115142017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao R, Guerrah A, Tang H and Zhao ZJ:
Cell surface glycoprotein PZR is a major mediator of concanavalin
A-induced cell signaling. J Biol Chem. 277:7882–7888. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fonseca NA, He Y, Greger L, Brazma A and
Zhang Z: Comprehensive genome and transcriptome analysis reveals
genetic basis for gene fusions in cancer. bioRxiv. 1486842017.
|
|
15
|
Zhao ZJ and Zhao R: Purification and
cloning of PZR, a binding protein and putative physiological
substrate of tyrosine phosphatase SHP-2. J Biol Chem.
273:29367–29372. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Playford MP and Schaller MD: The interplay
between Src and integrins in normal and tumor biology. Oncogene.
23:7928–7946. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Dong P, Zhang Y, Yang M, Chen Y
and Tian BL: Prognostic validation of the updated 8th edition
Tumor-Node- Metastasis classification by the Union for
international cancer control: Survival analyses of 307 patients
with surgically treated gallbladder carcinoma. Oncol Lett.
16:4427–4433. 2018.PubMed/NCBI
|
|
18
|
Uhlen M, Oksvold P, Fagerberg L, Lundberg
E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S,
et al: Towards a knowledge-based human protein atlas. Nature
Biotechnol. 28:1248–1250. 2010. View Article : Google Scholar
|
|
19
|
Dai Y, Qi L, Zhang X, Li Y, Chen M and Zu
X: CrkI and p130(Cas) complex regulates the migration and invasion
of prostate cancer cells. Cell Biochem Funct. 29:625–629. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Padhye A, Ungewiss C, Fradette JJ,
Rodriguez BL, Albritton JL, Miller JS and Gibbons DL: A novel ex
vivo tumor system identifies Src-mediated invasion and metastasis
in mesenchymal tumor cells in non-small cell lung cancer. Sci Rep.
9:48192019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu H, Jing X, Cheng X, He Y, Hu L, Wu H,
Ye F and Zhao R: Asporin enhances colorectal cancer metastasis
through activating the EGFR/src/cortactin signaling pathway.
Oncotarget. 7:73402–73413. 2016.PubMed/NCBI
|
|
22
|
Zhang XH, Wang Q, Gerald W, Hudis CA,
Norton L, Smid M, Foekens JA and Massagué J: Latent bone metastasis
in breast cancer tied to Src-dependent survival signals. Cancer
cell. 16:67–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang J, Asawa T, Takato T and Sakai R:
Cooperative roles of fyn and cortactin in cell migration of
metastatic murine melanoma. J Biol Chem. 278:48367–48376. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brábek J, Constancio SS, Siesser PF, Shin
NY, Pozzi A and Hanks SK: Crk-associated substrate tyrosine
phosphorylation sites are critical for invasion and metastasis of
SRC-transformed cells. Mol Cancer Res. 3:307–315. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parsons SJ and Parsons JT: Src family
kinases, key regulators of signal transduction. Oncogene.
23:7906–7909. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jia D, Jing Y, Zhang Z, Liu L, Ding J,
Zhao F, Ge C, Wang Q, Chen T, Yao M, et al: Amplification of
MPZL1/PZR promotes tumor cell migration through src-mediated
phosphorylation of cortactin in hepatocellular carcinoma. Cell Res.
24:204–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao R and Zhao ZJ: Dissecting the
interaction of SHP-2 with PZR, an immunoglobulin family protein
containing immunoreceptor tyrosine-based inhibitory motifs. J Biol
Chem. 275:5453–5459. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yeh YT, Dai HY and Chien CY: Amplification
of MPZL1/PZR gene in hepatocellular carcinoma. Hepatobiliary surg
Nutr. 3:87–90. 2014.PubMed/NCBI
|
|
30
|
Giannoni E, Buricchi F, Raugei G, Ramponi
G and Chiarugi P: Intracellular reactive oxygen species activate
Src tyrosine kinase during cell adhesion and anchorage-dependent
cell growth. Mol Cell Biol. 25:6391–6403. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shor AC, Keschman EA, Lee FY, Muro-Cacho
C, Letson GD, Trent JC, Pledger WJ and Jove R: Dasatinib inhibits
migration and invasion in diverse human sarcoma cell lines and
induces apoptosis in bone sarcoma cells dependent on SRC kinase for
survival. Cancer Res. 67:2800–2808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu H and Jove R: The STATs of cancer-new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mitra SK and Schlaepfer DD:
Integrin-regulated FAK-src signaling in normal and cancer cells.
Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vuori K and Ruoslahti E: Tyrosine
phosphorylation of p130Cas and cortactin accompanies
integrin-mediated cell adhesion to extracellular matrix. J Biol
Chem. 270:22259–22262. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ammer AG, Kelley LC, Hayes KE, Evans JV,
Lopez-Skinner LA, Martin KH, Frederick B, Rothschild BL, Raben D,
Elvin P, et al: Saracatinib impairs head and neck squamous cell
carcinoma invasion by disrupting invadopodia function. J Cancer Sci
Ther. 1:52–61. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Agerer F, Lux S, Michel A, Rohde M, Ohlsen
K and Hauck CR: Cellular invasion by Staphylococcus aureus
reveals a functional link between focal adhesion kinase and
cortactin in integrin-mediated internalisation. J Cell Sci.
118:2189–2200. 2005. View Article : Google Scholar : PubMed/NCBI
|
